Earnings Preview: Sarepta Therapeutics
Portfolio Pulse from Benzinga Insights
Sarepta Therapeutics (NASDAQ:SRPT) is set to release its latest quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $-1.89. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. The stock was trading at $108.39 as of July 31, with a 52-week increase of 11.14%.
August 04, 2023 | 10:17 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sarepta Therapeutics is expected to report an EPS of $-1.89 in its upcoming earnings report. The company's history of beating EPS estimates could potentially lead to a positive impact on its share price.
Sarepta Therapeutics has a history of beating EPS estimates, which has often led to an increase in its share price. If the company beats the estimated EPS of $-1.89, it could potentially lead to a positive impact on its share price. However, the actual impact will also depend on the company's guidance for the next quarter.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100